A case of chronic hepatitis C with sinus bradycardia during IFN therapy

Kurume Medical Journal

Volumn 45, Issue 1, 1998, Pages 161-163

  Sasaki, Masaru ^a   Sata, Michio ^a   Suzuki, Hiroshi ^a   Tanikawa, Kyuichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; IFN; Sinus bradycardia

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; AMBULATORY MONITORING; ARTICLE; CARDIOTOXICITY; CASE REPORT; CHRONIC HEPATITIS; DOSE RESPONSE; DRUG EFFECT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEPATITIS C; HUMAN; MALE; SINUS BRADYCARDIA;

EID: 0031867024     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.45.161     Document Type: Article

References (6)

1. Sainokami S, Hino K, Shimoda K, and Niwa H. Clinical analysis of patients with chronic hepatitis C who discontinued interferon treatment because of side effect -our experimcnce and recent reports- Nipponrinsho 1994; 52:205-210. (in Japanese)
2. Sartori M, Andorno M, La TG, Pozzoli G, Rudoni M et al. Assesment of interferon cardiotoxicity with quantitative radionuclide angiocardiography. European Journal of Clinical Investigation 1995; 25:68-70.
3. Sonnenblick M, and Rosin A. Cardiotoxicity of interferon. A review of 44 cases. Chest 1991; 99:557-561.
4. Blalock JD, and Stanton JD. Comon pathways of interferon and hormonal acition. Nature 1980; 283:406-408.
5. Lampidis TJ, and Brouty-Bote D. Interferon inhibits cardiac cell function in vitro. Proc Soc Exp Biol Med 1981; 166:181-185.
6. Zbinden G. Effect of recombinant human alphainterferon in a rodent cardiotoxicity model. Toxicol Lett 1990; 50:25-35.